HTFL

Heartflow, Inc. Common Stock$27.45+1.97 (+7.73%)

Prev Close$25.49·MCap$2.30B·P/E—·Vol864.1K·Yield—

▲

Buys (12M)

$1.05M

▼

Sells (12M)

$125.60M

◆

Net Activity

Net Seller

$124.55M

●

Active Insiders

last 12 mo

Over the past 12 months, insider activity at Heartflow, Inc. Common Stock (HTFL) has been dominated by selling, with 1 insider purchase totaling $1.05M and 16 insider sales totaling $125.60M. The most recent insider transaction was by Farquhar John C.M. (director, officer: Chief Executive Officer), who sold $626.1K worth of shares on Jul 13, 2026. Heartflow, Inc. Common Stock operates in the Healthcare sector, within the Medical - Healthcare Information Services industry, with a market cap of $2.30B.

HTFL Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Jul 13, 2026	Farquhar John C.M.	director, officer: Chief Executive Officer	Sell	22,562	$27.75	$626.1K	435,373
Jun 26, 2026	Farquhar John C.M.	director, officer: Chief Executive Officer	Sell	38,900	$35.00	$1.36M	457,935
Jun 12, 2026	Farquhar John C.M.	director, officer: Chief Executive Officer	Sell	22,562	$28.50	$643.0K	496,835
May 20, 2026	Rogers Campbell	officer: Chief Medical Officer	Sell	9,219	$28.34	$261.3K	78,731
May 13, 2026	Farquhar John C.M.	director, officer: Chief Executive Officer	Sell	22,562	$29.12	$657.0K	519,397
Apr 30, 2026	Bain Capital Life Sciences Investors, LLC	10 percent owner	Sell	2,000,000	$29.45	$58.90M2.3% OS	10,194,048
Apr 14, 2026	Farquhar John C.M.	director, officer: Chief Executive Officer	Sell	22,562	$26.72	$602.9K	549,163
Mar 23, 2026	Rogers Campbell	officer: Chief Medical Officer	Sell	64,533	$25.69	$1.66M	78,518-45%
Mar 20, 2026	Farquhar John C.M.	director, officer: Chief Executive Officer	Sell	9,725	$25.00	$243.1K	571,725
Mar 12, 2026	Farquhar John C.M.	director, officer: Chief Executive Officer	Sell	12,837	$22.66	$290.9K	581,450
Mar 6, 2026	Cullivan Julie A	director	Sell	9,122	$25.00	$228.1K	27,291-25%
Feb 17, 2026	Rogers Campbell	officer: Chief Medical Officer	Sell	65,153	$24.49	$1.60M	76,034-46%
Feb 12, 2026	Rogers Campbell	Chief Medical Officer	Sell	65,153	$24.49	$1.60M	0
Feb 10, 2026	Farquhar John C.M.	director, officer: Chief Executive Officer	Sell	22,562	$27.46	$619.6K	591,656
Feb 6, 2026	Bain Capital Life Sciences Investors, LLC	10 percent owner	Sell	2,000,000	$28.05	$56.10M2.3% OS	10,448,158
Feb 6, 2026	Cullivan Julie A	director	Sell	8,000	$27.32	$218.6K	36,413
Dec 17, 2025	Lightcap Jeffrey C	Director	Buy	40,000	$26.34	$1.05M	40,000

HTFL Insider Buying Activity

The following table shows recent insider purchases of Heartflow, Inc. Common Stock (HTFL) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Dec 17, 2025	Lightcap Jeffrey C	Director	Buy	40,000	$26.34	$1.05M	40,000

HTFL Insider Selling Activity

The following table shows recent insider sales of Heartflow, Inc. Common Stock (HTFL) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Jul 13, 2026	Farquhar John C.M.	director, officer: Chief Executive Officer	Sell	22,562	$27.75	$626.1K	435,373
Jun 26, 2026	Farquhar John C.M.	director, officer: Chief Executive Officer	Sell	38,900	$35.00	$1.36M	457,935
Jun 12, 2026	Farquhar John C.M.	director, officer: Chief Executive Officer	Sell	22,562	$28.50	$643.0K	496,835
May 20, 2026	Rogers Campbell	officer: Chief Medical Officer	Sell	9,219	$28.34	$261.3K	78,731
May 13, 2026	Farquhar John C.M.	director, officer: Chief Executive Officer	Sell	22,562	$29.12	$657.0K	519,397
Apr 30, 2026	Bain Capital Life Sciences Investors, LLC	10 percent owner	Sell	2,000,000	$29.45	$58.90M2.3% OS	10,194,048
Apr 14, 2026	Farquhar John C.M.	director, officer: Chief Executive Officer	Sell	22,562	$26.72	$602.9K	549,163
Mar 23, 2026	Rogers Campbell	officer: Chief Medical Officer	Sell	64,533	$25.69	$1.66M	78,518-45%
Mar 20, 2026	Farquhar John C.M.	director, officer: Chief Executive Officer	Sell	9,725	$25.00	$243.1K	571,725
Mar 12, 2026	Farquhar John C.M.	director, officer: Chief Executive Officer	Sell	12,837	$22.66	$290.9K	581,450
Mar 6, 2026	Cullivan Julie A	director	Sell	9,122	$25.00	$228.1K	27,291-25%
Feb 17, 2026	Rogers Campbell	officer: Chief Medical Officer	Sell	65,153	$24.49	$1.60M	76,034-46%
Feb 12, 2026	Rogers Campbell	Chief Medical Officer	Sell	65,153	$24.49	$1.60M	0
Feb 10, 2026	Farquhar John C.M.	director, officer: Chief Executive Officer	Sell	22,562	$27.46	$619.6K	591,656
Feb 6, 2026	Bain Capital Life Sciences Investors, LLC	10 percent owner	Sell	2,000,000	$28.05	$56.10M2.3% OS	10,448,158
Feb 6, 2026	Cullivan Julie A	director	Sell	8,000	$27.32	$218.6K	36,413